Prevalence of calcific aortic valve disease in the elderly and associated risk factors: A population-based study in a Mediterranean area

European Journal of Preventive Cardiology

Volumn 20, Issue 6, 2013, Pages 1022-1030

  Ferreira González, Ignacio ^a,b,c   Pinar Sopena, Josep ^a,b,c   Ribera, Aida ^a,b,c   Marsal, Josep r ^c   Cascant, Purificación ^a,b,c   González Alujas, Teresa ^a,c   Evangelista, Arturo ^a,c   Brotons, Carlos ^d   Moral, Irene ^d   Permanyer Miralda, Gaietà ^a,b,c   García Dorado, David ^a,c   Tornos, Pilar ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Red de Enfemedades Cardiovasculares ^*  (Spain)

^d BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

Author keywords

Aortic valve sclerosis; aortic valve stenosis; calcific aortic valve disease; cardiovascular risk factors

Indexed keywords

AGE; AGED; AORTA VALVE; AORTA VALVE STENOSIS; AORTIC VALVE SCLEROSIS; ARTICLE; CALCIFIC AORTIC VALVE DISEASE; CALCINOSIS; CARDIOVASCULAR RISK FACTORS; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; OBESITY; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; RISK; RISK FACTOR; SCLEROSIS; SEVERITY OF ILLNESS INDEX; SMOKING; SPAIN; STATISTICAL MODEL; VERY ELDERLY;

AORTIC VALVE SCLEROSIS; AORTIC VALVE STENOSIS; CALCIFIC AORTIC VALVE DISEASE; CARDIOVASCULAR RISK FACTORS;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RISK FACTORS; SCLEROSIS; SEVERITY OF ILLNESS INDEX; SMOKING; SPAIN;

EID: 84905207601     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312451238     Document Type: Article

References (23)

1. Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis working group. Executive summary: Calcific aortic valve disease − 2011 update. Circulation 2011; 124(16): 1783–1791.
2. Ngo DT, Sverdlov AL, Willoughby SR, et al. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc Imaging 2009; 2(8): 919–927.
3. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111(24): 3316–3326.
4. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med 1987; 317(2): 91–98.
5. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142–147.
6. Aronow WS, Ahn C, Kronzon I. Association of mitral annular calcium and of aortic cuspal calcium with coronary artery disease in older patients. Am J Cardiol 1999; 84(9): 1084–1085, A9.
7. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987; 59(9): 998–999.
8. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21(5): 1220–1225.
9. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 630–634.
10. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001; 38(3): 827–834.
11. Branch KR, O’Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep 2002; 4(2): 111–117.
12. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368: 1005–1011.
13. Gyberg V, Ryden L. Policymakers’ perceptions of cardiovascular health in Europe. Eur J Cardiovasc Prev Rehabil 2011; 18(5): 745–753.
14. de Lorgeril M, Salen P, Paillard F, et al. Mediterranean diet and the French paradox: two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease. Cardiovasc Res 2002; 54(3): 503–515.
15. Beckman JA, Higgins CO, Gerhard-Herman M. Automated oscillometric determination of the ankle–brachial index provides accuracy necessary for office practice. Hypertension 2006; 47(1): 35 38–38.
16. Criqui MH, McClelland RL, McDermott MM, et al. The ankle–brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 56(18): 1506–1512.
17. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18(12): 1440–1463.
18. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, et al. Assessment of severity of aortic regurgitation using the width of the vena contracta: a clinical color Doppler imaging study. Circulation 2000; 102(5): 558–564.
19. Demer LL. Cholesterol in vascular and valvular calcification. Circulation 2001; 104(16): 1881–1883.
20. O’Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16(4): 523–532.
21. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999; 19(5): 1218–1222.
22. O’Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006; 26(8): 1721–1728.
23. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352(23): 2389–2397.